Press Releases on January 13, 2020 - EIN Presswire - Press Release Distribution Service

Published on January 13, 2020 - 12:00 GMT

Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy ...

-Phase 1 clinical trial of off-the-shelf (allogeneic) anti-BCMA CAR T therapy candidate for patients with relapsed/refractory multiple myeloma expected to begin dosing patients in 2020- -PBCAR269A has received Orphan Drug Designation from the FDA for the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2020 - 12:00 GMT

Gofire, Inc. Founder and Chairman Peter Calfee to Present at 2020 ICR Conference

DENVER, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Gofire™, Inc. an innovator of hardware and software solutions that aid in dose delivery, health tracking, and medication management via connected devices, announced today that the company’s Founder and Chairman of …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on January 13, 2020 - 12:00 GMT

Denny’s Corporation Releases Preliminary Financial Results for Fourth Quarter and Fiscal Year 2019

- Company Reiterates 2019 Guidance Expectations for Adjusted EBITDA* - SPARTANBURG, S.C., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Denny’s Corporation (NASDAQ: DENN), franchisor and operator of one of America's largest franchised full-service restaurant …

Distribution channels:

Published on January 13, 2020 - 12:00 GMT

Liteye Systems Delivers Another $10M in CUAS Solutions!

Centennial, CO, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Centennial Colorado — Liteye Systems, Inc, a world leader in Counter Unmanned Aerial Systems (CUAS), announced the shipment of an additional $10M of US AUDS systems. The recent delivery of Liteye’s US …

Distribution channels: Media, Advertising & PR ...

Published on January 13, 2020 - 12:00 GMT

Destination XL Group, Inc. Announces Holiday Sales Results

CANTON, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ:DXLG), the largest omni-channel specialty retailer of big and tall men's apparel, today announced that total sales for the 9-week holiday sales period ended January 4, …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on January 13, 2020 - 12:00 GMT

Cyclerion announces IW-6463 phase 1 healthy volunteer study results that support further development for neurodegenerative ...

– Results in 110 subjects demonstrate favorable safety, CNS pharmacokinetics, and evidence of target engagement – – Study underway in elderly subjects to further assess cerebral blood flow and additional translational measures of CNS target engagement; …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on January 13, 2020 - 12:00 GMT

Replimune Provides 2019 Year End Corporate Update and Reviews Expected 2020 Milestones

RP1: Registration-directed randomized controlled Phase 2 clinical trial of RP1 in combination with cemiplimab-rwlc (Libtayo®) in cutaneous squamous cell carcinoma (CSCC) underway RP1: Study of RP1 as a monotherapy in solid organ transplant recipients with …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2020 - 12:00 GMT

Organogenesis Holdings Inc. Reports Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2019

CANTON, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on January 13, 2020 - 12:00 GMT

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance

ALACHUA, Fla., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2019 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on January 13, 2020 - 12:00 GMT

Chiasma Announces FDA Acceptance of MYCAPSSA® New Drug Application Resubmission

FDA sets PDUFA date of June 26, 2020 Acceptance follows December 26, 2019 NDA resubmission NEEDHAM, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 13, 2020 - 12:00 GMT

Premier Health Closes Acquisition of Livecare

Livecare is an established leader in the Canadian digital health space Have provided over 27,000 telemedicine visits Service over 500 independent active health practitioner accounts, some of which are multi-user sites VANCOUVER, British Columbia, Jan. 13, …

Distribution channels: Media, Advertising & PR

Published on January 13, 2020 - 12:00 GMT

Black Diamond Group Announces 2020 Capital Spending Plan and Approval of Normal Course Issuer Bid

CALGARY, Alberta, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (“Black Diamond” or “the Company”) (TSX: BDI) announced that the Board of Directors has approved the 2020 capital budget of $35 million. Black Diamond also announced that it …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on January 13, 2020 - 12:00 GMT

Mesa Air Group Reports December 2019 Operating Performance

PHOENIX, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) today reported Mesa Airlines’ operating performance for December 2019. Mesa Airlines reported 39,212 block hours in December 2019, up more than one percent from December 2018. …

Distribution channels: Aviation & Aerospace Industry, Media, Advertising & PR ...

Published on January 13, 2020 - 12:00 GMT

Neovasc Inc. Investor Update

VANCOUVER, Jan. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 13, 2020 - 12:00 GMT

Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance

2020 Galafold Revenue Guidance of $250M-$260M Focused on Pompe Phase 3 PROPEL study and manufacturing to support 2021 BLA and MAA Continued Progress Across Industry Leading Rare Disease Gene Therapy Portfolio Strong Balance Sheet with $450M+ Cash – Cash …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...

Published on January 13, 2020 - 12:00 GMT

Delta Apparel Announces Preliminary First Quarter Results

GREENVILLE, S.C., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Delta Apparel, Inc. (NYSE American: DLA), a leading provider of core activewear and lifestyle apparel, today announced preliminary results for its 2020 fiscal first quarter ended December 28, 2019. The …

Distribution channels:

Published on January 13, 2020 - 12:00 GMT

Orchard Therapeutics Highlights 2020 Strategic Priorities

Commercial Preparations on Track for Potential 2020 EU Launch of OTL-200 for Metachromatic Leukodystrophy (MLD) with U.S. Regulatory Filing Expected Late 2020 / Early 2021 Initiation of Rolling U.S. Regulatory Filing for OTL-101 (ADA-SCID) Planned for 1H …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on January 13, 2020 - 12:00 GMT

Cyclacel Pharmaceuticals Reviews 2019 Achievements and Announces Key Business Objectives for 2020

– Anticancer Activity of CYC065 Monotherapy in Patients with MCL1 Amplified Solid Tumors and CYC065-venetoclax combination in AML/MDS and CLL dose escalation studies – BERKELEY HEIGHTS, N.J., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, …

Distribution channels:

Published on January 13, 2020 - 12:00 GMT

GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2019

CARLSBAD, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary operational and financial results for the year ended …

Distribution channels: Media, Advertising & PR, Technology ...

Published on January 13, 2020 - 12:00 GMT

CareDx Reports Preliminary Fourth Quarter and Full Year 2019 Results

SOUTH SAN FRANCISCO, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...